SCHEDULE 13D

Company

AXIM BIOTECHNOLOGIES, INC.

Filed

April 28, 2014

Accession Number

0001078782-14-000743

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →